Mendel, D B <br/><br/>
Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent.  [electronic resource] 

 -  Anti-cancer drug design  Feb 2000 
 - 29-41 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0266-9536 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Enzyme Inhibitors--pharmacology<br/>Humans<br/>Indoles--pharmacology<br/>Pyrroles--pharmacology<br/>Receptor Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Receptors, Growth Factor--antagonists & inhibitors<br/>Receptors, Vascular Endothelial Growth Factor